Regulatory Approvals And Launches Will Expand Decentralized Healthcare Access
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
04 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$5.50
94.7% undervalued intrinsic discount15 Aug
US$0.29
1Y
-78.4%7D
15.7%